A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies

Clinical trial NCT05201183 · WITHDRAWN

Trial details

NCT number: NCT05201183
Sponsor: Naoyuki G. Saito, M.D., Ph.D.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Chronic Myeloid Leukemia Acute Lymphocytic Leukemia Myelodysplastic Syndromes

Start date: 2023-10-01
Primary completion: 2027-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.